ArticleHuman reproduction open2026
Intercornual distance and postoperative reproductive outcomes in moderate-to-severe intrauterine adhesions: a retrospective cohort study.
Article in Human reproduction open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
study questionDoes intercornual distance (ICD), as reflected by intrauterine stent size during hysteroscopic adhesiolysis, have an association with reproductive outcomes and provide information for postoperative risk stratification in women with moderate-to-severe intrauterine adhesions? SUMMARY ANSWER: A smaller ICD was independently associated with a lower likelihood of clinical pregnancy within 1 year of the final hysteroscopy and may offer additional information for postoperative risk stratification in women with moderate-to-severe intrauterine adhesions. WHAT IS KNOWN ALREADY: Reproductive outcomes following treatment for moderate-to-severe intrauterine adhesions vary considerably. Existing severity classifications offer limited discrimination within this group. The potential association between ICD and postoperative reproductive outcomes has not been systematically evaluated. STUDY DESIGN SIZE DURATION: Retrospective cohort study conducted at a tertiary academic center from November 2022 to October 2023. A total of 560 women were included, with up to 2 years of follow-up. PARTICIPANTS/MATERIALS SETTING
methodsRetrospective single-center cohort of women aged 18-44 years with moderate-to-severe intrauterine adhesions (American Fertility Society [AFS] score ≥ 5) undergoing standardized hysteroscopic management with adhesiolysis, intrauterine stent placement, and scheduled second-look hysteroscopy. ICD was reflected by intraoperatively selected stent size, categorized into ordered levels (XXXS-XXXL) and dichotomized using an XS threshold (∼20-22 mm). Postoperative ultrasound-derived ICD was analyzed for supportive evaluation. The primary outcome was clinical pregnancy within 1 year of the final hysteroscopy. Associations were examined using multivariable logistic regression with sensitivity analyses. The incremental predictive value and clinical utility of stent-size classification (≤XS vs >XS) beyond established clinical variables were evaluated using discrimination, calibration, and decision-curve analyses. MAIN RESULTS AND THE ROLE OF CHANCE: Women in the ≤XS group had lower odds of clinical pregnancy within 1 year of the final hysteroscopy compared with those in the >XS group (adjusted odds ratio [aOR] = 0.447, 95% CI 0.255-0.786; LIMITATIONS REASONS FOR CAUTION: This single-center retrospective study may limit generalizability and is subject to selection bias and residual confounding. Prospective multicenter validation is required. WIDER IMPLICATIONS OF THE
findingsICD may provide additional information for postoperative risk stratification in women with moderate-to-severe intrauterine adhesions. STUDY FUNDING/COMPETING INTERESTS: This study was supported by Scientific and Technological Project of Furong Laboratory (Gynecological Disease and Reproductive Health) (No. 2023SK2109) and Key Research Project of National Key Clinical Specialties, Health Commission of Hunan Province (Z2023068), China. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.